Authors say the intervention warrants evaluation in a randomized controlled trial<\/p>\n<\/h3>\n
By Lori Solomon HealthDay Reporter<\/b>
\n<\/b><\/p>\n
TUESDAY, April 8, 2025 (HealthDay News) — A mobile health (mHealth)-supported home-delivered physical activity (PA) intervention is feasible and effective at promoting sustained, purposeful exercise in adults with newly diagnosed diabetes, according to a study published online March 26 in BMJ Open<\/em>.<\/p>\n Katie Hesketh, Ph.D., from University of Birmingham in the United Kingdom, and colleagues assessed the feasibility of an mHealth-supported home-delivered PA intervention (MOTIVATE-T2D) in adults with recently diagnosed type 2 diabetes. The analysis included 125 participants randomly assigned (1:1) to intervention (MOTIVATE-T2D) or active control groups.<\/p>\n The researchers found that MOTIVATE-T2D participants were more likely to start (odds ratio [OR], 10.4) and maintain purposeful exercise at six (OR, 7.1) and 12\u2009months (OR, 2.9). An exploratory analysis showed a potential effect in favor of MOTIVATE-T2D, including proposed primary outcomes hemoglobin A1c (HbA1c) and systolic blood pressure in a future randomized controlled trial (between-group mean differences: HbA1c at six months, \u22125 percent change from baseline; HbA1c at 12\u2009months, \u22122 percent change from baseline; systolic blood pressure at six\u2009months, \u22121\u2009mm Hg; systolic blood pressure at 12\u2009months, \u22124\u2009mm Hg).<\/p>\n “The results from this trial suggest that the MOTIVATE-T2D approach of using biometrics from wearable technologies to support a home-delivered, personalized behavioral counseling service was promising for the promotion, uptake, and adherence to purposeful exercise in people with newly diagnosed type 2 diabetes,” the authors write.<\/p>\n